Zasocitinib: Clinical Trials

7 trials of Zasocitinib, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 recruiting, 2 not yet recruiting, 1 active not recruiting, 1 completed. 7 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 37Recruiting 3, Not yet recruiting 2, Active not recruiting 1, Completed 1

Follow Zasocitinib: new trials by email Literature Review of Zasocitinib trials Research Report on Zasocitinib

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Zasocitinib in Adults With Psoriatic Arthritis (LATITUDE PsA NeXt)
Placebo, Zasocitinib - Psoriatic Arthritis
Phase 3Not yet recruitingTakeda6442027-01-112026-10-27
A Study of Zasocitinib in Adults With Non-pustular Palmoplantar Psoriasis
Zasocitinib - Palmoplantar Psoriasis
Phase 3Not yet recruitingTakeda402026-11-012026-10-20
Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
Zasocitinib - Psoriatic Arthritis
Phase 3RecruitingTakeda11822026-03-112026-09-09
A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis
Zasocitinib, Placebo - Plaque Psoriasis
Phase 3RecruitingTakeda1102025-12-042026-09-09
A Study Comparing Zasocitinib (TAK-279) With Deucravacitinib in Adults With Plaque Psoriasis
Zasocitinib, Deucravacitinib, Placebo to match zasocitinib - Plaque Psoriasis
Phase 3CompletedTakeda6062025-07-092026-05-01
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
Zasocitinib, Placebo - Psoriatic Arthritis
Phase 3Active not recruitingTakeda6012025-03-102026-10-14
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
Zasocitinib, Active Comparator, Placebo - Psoriatic Arthritis
Phase 3RecruitingTakeda10882025-03-032026-10-14

Conditions studied

Arthritis, Psoriatic (4)  ·  Psoriasis (1)

Sponsors

Takeda (7)

Countries

Poland (5)  ·  United States (5)  ·  Germany (4)  ·  Japan (4)  ·  Spain (4)  ·  China (3)  ·  Czechia (3)  ·  Latvia (3)  ·  Australia (2)  ·  Bulgaria (2)  ·  Canada (2)  ·  Croatia (2)  ·  Estonia (2)  ·  France (2)  ·  Hungary (2)

NIH funding

2025 (2)